Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of Anixa Biosciences Inc from Q4 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Anixa Biosciences Inc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q4 2019 to Q2 2025.
  • Anixa Biosciences Inc Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Jul 2025 was $64,000, a 1.59% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $64,000 +$1,000 +1.6% 31 Jul 2025 10-Q 10 Sep 2025 2025 Q3
Q1 2025 $64,000 -$1,000 -1.5% 30 Apr 2025 10-Q 28 May 2025 2025 Q2
Q4 2024 $64,000 -$1,000 -1.5% 31 Jan 2025 10-Q 11 Mar 2025 2025 Q1
Q3 2024 $63,000 -$7,000 -10% 31 Oct 2024 10-K 10 Jan 2025 2024 FY
Q2 2024 $63,000 -$7,000 -10% 31 Jul 2024 10-Q 06 Sep 2024 2024 Q3
Q1 2024 $65,000 -$5,000 -7.1% 30 Apr 2024 10-Q 04 Jun 2024 2024 Q2
Q4 2023 $65,000 -$5,000 -7.1% 31 Jan 2024 10-Q 12 Mar 2024 2024 Q1
Q3 2023 $70,000 +$3,000 +4.5% 31 Oct 2023 10-K 16 Jan 2024 2023 FY
Q2 2023 $70,000 +$3,000 +4.5% 31 Jul 2023 10-Q 06 Sep 2023 2023 Q3
Q1 2023 $70,000 +$4,000 +6.1% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 $70,000 +$4,000 +6.1% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $67,000 +$1,509 +2.3% 31 Oct 2022 10-K 04 Jan 2023 2022 FY
Q2 2022 $67,000 31 Jul 2022 10-Q 09 Sep 2022 2022 Q3
Q1 2022 $66,000 30 Apr 2022 10-Q 10 Jun 2022 2022 Q2
Q4 2021 $66,000 31 Jan 2022 10-Q 11 Mar 2022 2022 Q1
Q3 2021 $65,491 31 Oct 2021 10-K 04 Jan 2022 2022 FY
Q1 2020 $59,136 30 Apr 2020 10-Q 09 Jun 2020 2020 Q2
Q4 2019 $59,136 31 Jan 2020 10-Q 09 Mar 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.